These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16435072)

  • 1. Effect of matrix metalloproteinase inhibition by doxycycline on myocardial healing and remodeling after myocardial infarction.
    Tessone A; Feinberg MS; Barbash IM; Reich R; Holbova R; Richmann M; Mardor Y; Leor J
    Cardiovasc Drugs Ther; 2005 Dec; 19(6):383-90. PubMed ID: 16435072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling.
    Villarreal FJ; Griffin M; Omens J; Dillmann W; Nguyen J; Covell J
    Circulation; 2003 Sep; 108(12):1487-92. PubMed ID: 12952845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline ameliorates ischemic and border-zone remodeling and endothelial dysfunction after myocardial infarction in rats.
    Camp TM; Tyagi SC; Aru GM; Hayden MR; Mehta JL; Tyagi SC
    J Heart Lung Transplant; 2004 Jun; 23(6):729-36. PubMed ID: 15366434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
    Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1288-93. PubMed ID: 15387968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial infarct expansion and matrix metalloproteinase inhibition.
    Mukherjee R; Brinsa TA; Dowdy KB; Scott AA; Baskin JM; Deschamps AM; Lowry AS; Escobar GP; Lucas DG; Yarbrough WM; Zile MR; Spinale FG
    Circulation; 2003 Feb; 107(4):618-25. PubMed ID: 12566376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of timed administration of doxycycline or methylprednisolone on post-myocardial infarction inflammation and left ventricular remodeling in the rat heart.
    Garcia RA; Go KV; Villarreal FJ
    Mol Cell Biochem; 2007 Jun; 300(1-2):159-69. PubMed ID: 17149544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
    Yarbrough WM; Mukherjee R; Escobar GP; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Lowry AS; O'Neill TP; Spinale FG
    Circulation; 2003 Oct; 108(14):1753-9. PubMed ID: 12975256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxycycline ameliorates aggregation of collagen and atrial natriuretic peptide in murine post-infarction heart.
    Zhu H; Sun X; Wang D; Hu N; Zhang Y
    Eur J Pharmacol; 2015 May; 754():66-72. PubMed ID: 25724785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction.
    Lindsey ML; Gannon J; Aikawa M; Schoen FJ; Rabkin E; Lopresti-Morrow L; Crawford J; Black S; Libby P; Mitchell PG; Lee RT
    Circulation; 2002 Feb; 105(6):753-8. PubMed ID: 11839633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
    Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
    Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of MMP/TIMP by HUVEC transplantation attenuates ventricular remodeling in response to myocardial infarction.
    Kwon JS; Kim YS; Cho AS; Cho HH; Kim JS; Hong MH; Jeong HY; Kang WS; Hwang KK; Bae JW; Jeong MH; Cho MC; Ahn Y
    Life Sci; 2014 Apr; 101(1-2):15-26. PubMed ID: 24560960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac remodeling by fibrous tissue after infarction in rats.
    Sun Y; Zhang JQ; Zhang J; Lamparter S
    J Lab Clin Med; 2000 Apr; 135(4):316-23. PubMed ID: 10779047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
    Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):53-61. PubMed ID: 15782494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective targeting of matrix metalloproteinase inhibition in post-infarction myocardial remodeling.
    Apple KA; Yarbrough WM; Mukherjee R; Deschamps AM; Escobar PG; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Stroud RE; O'Neill TP; Spinale FG
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):228-35. PubMed ID: 16495760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure.
    Peterson JT; Hallak H; Johnson L; Li H; O'Brien PM; Sliskovic DR; Bocan TM; Coker ML; Etoh T; Spinale FG
    Circulation; 2001 May; 103(18):2303-9. PubMed ID: 11342481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
    Purcell BP; Barlow SC; Perreault PE; Freeburg L; Doviak H; Jacobs J; Hoenes A; Zellars KN; Khakoo AY; Lee T; Burdick JA; Spinale FG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H814-H825. PubMed ID: 29979624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis.
    Friehs I; Margossian RE; Moran AM; Cao-Danh H; Moses MA; del Nido PJ
    Basic Res Cardiol; 2006 May; 101(3):204-13. PubMed ID: 16369727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.
    Hudson MP; Armstrong PW; Ruzyllo W; Brum J; Cusmano L; Krzeski P; Lyon R; Quinones M; Theroux P; Sydlowski D; Kim HE; Garcia MJ; Jaber WA; Weaver WD
    J Am Coll Cardiol; 2006 Jul; 48(1):15-20. PubMed ID: 16814643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction.
    Krishnamurthy P; Peterson JT; Subramanian V; Singh M; Singh K
    Mol Cell Biochem; 2009 Feb; 322(1-2):53-62. PubMed ID: 18979185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.